GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Forward PE Ratio

International Biotechnology Trust (LSE:IBT) Forward PE Ratio : 0.00 (As of Jun. 20, 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Forward PE Ratio?

International Biotechnology Trust's Forward PE Ratio for today is 0.00.

International Biotechnology Trust's PE Ratio without NRI for today is 13.30.

International Biotechnology Trust's PE Ratio for today is 13.30.


International Biotechnology Trust Forward PE Ratio Historical Data

The historical data trend for International Biotechnology Trust's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Forward PE Ratio Chart

International Biotechnology Trust Annual Data
Trend 2022-12 2023-04
Forward PE Ratio
769.23 714.29

International Biotechnology Trust Semi-Annual Data
2022-12 2023-03
Forward PE Ratio 769.23 714.29

Competitive Comparison of International Biotechnology Trust's Forward PE Ratio

For the Biotechnology subindustry, International Biotechnology Trust's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Forward PE Ratio falls into.



International Biotechnology Trust Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


International Biotechnology Trust  (LSE:IBT) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


International Biotechnology Trust Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust (LSE:IBT) Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines